Decreased platelet serotonin concentration in Alzheimer's disease with involuntary emotional expression disorder

Neuroscience Letters

Volumn 578, Issue , 2014, Pages 71-74

  Prokšelj, Tatjana ^a   Jerin, Aleš ^b   Muck Seler, Dorotea ^c   Kogoj, Aleš ^d  

^a Psychiatric Hospital Begunje   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c RUDER BO KOVI INSTITUTE   (Croatia)

^d UNIVERSITY PSYCHIATRIC HOSPITAL   (Slovenia)

Author keywords

Affective symptoms; Aggression, Blood platelets; Alzheimer's disease; Emotional disturbances; Serotonin

Indexed keywords

SEROTONIN;

ADULT; AGED; AGGRESSION; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYING; DSM-IV-TR; EMOTIONAL DISORDER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INVOLUNTARY EMOTIONAL EXPRESSION DISORDER; MALE; MINI MENTAL STATE EXAMINATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONVERBAL COMMUNICATION; OVERT AGGRESSION SCALE MODIFIED; PATHOLOGICAL LAUGHTER AND CRYING SCALE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; THROMBOCYTE; VERBAL HOSTILITY; BLOOD; CHEMISTRY; COMPLICATION; MIDDLE AGED; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGGRESSION; ALZHEIMER DISEASE; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROTONIN;

EID: 84903825401     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.06.034     Document Type: Article

References (31)

1. Cummings J.L., Cole G. Alzheimer disease. JAMA 2002, 287:2335-2338.
2. Mega M.S., Cummings J.L., Fiorello T., Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996, 46:130-135.
3. Brodaty H., Draper B., Saab D., Low L.F., Richards V., Paton H., Lie D. Psychosis, depression and behavioral disturbances in Sydney nursing home residents; prevalence and predictors. Int. J. Geriatr. Psychiatry 2011, 16:504-512.
4. Starkstein S.E., Migliorelli R., Tesón A., Petracca G., Chemerinsky E., Manes F., Chemerinsky E., Leiguarda R. Prevalence and clinical correlates of pathological affective display in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1995, 59:55-60.
5. Cummings J.L., Arciniegas D.B., Brooks B.R., Herndon R.M., Lauterbach E.C., Pioro E.P., Robinson R.G., Scharre D.W., Schiffer R.B., Weintraub D. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr. 2006, 11:1-7.
6. Garcia-Alloza M., Gil-Bea F.J., Diez-Ariza M., Chen C.P.L.-H., Francis P.T., Lasheras B., Ramirez M.J. Cholinergic-serotonergic imbalance contributes to cognitive and behavioural symptoms in Alzheimer's disease. NeuroPsychologia 2005, 43:442-449.
7. Palmer A.M., Stratman G.C., Procter A.W., Bowen D.M. Possible neurotransmitters basis of behavioral changes in Alzheimer's disease. Ann. Neurol. 1988, 23:616-620.
8. Lai M.K.P., Tsang S.W.Y., Francis P.T., Keene J., Hope T., Esiri M.M., Spence I., Chen C.P.L. Post-mortem serotonergic correlates of cognitive decline in Alzheimer's disease. NeuroReport 2002, 13:1175-1178.
9. Brooks B.R., Thisted R.A., Appel S.H., Bradley W.G., Olney R.K., Berg J.E., Pope L.E., Smith R.A. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 2004, 63:1364-1370.
10. Kepe V., Barrio J.R., Huang S.-C., Ercoli L., Siddarth P., Shoghi-Jadid K., Cole G.M., Satyamurthy N., Cummings J.L., Small G.W., Phelps M.E. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc. Nat. Acad. Sci. U.S.A. 2006, 103:702-707.
11. Blin J., Baron J.C., Dubois B., Crouzel C., Fiorelli M., Attar-Levy D., Pillon B., Fournier D., Vidailhet M., Agid Y. Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone. Brain 1993, 116:497-510.
12. Lanctôt K.L., Herrmann N., Mazzotta P. Role of serotonin in the behavioral and psychological symptoms of dementia. J. Neuropsychiatry Clin. Neurosci. 2001, 13:5-21.
13. Cocchi M., Tonello L., Gabrielli F. Considerations on blood platelets: a neuron's mirror for mood disorders?. Open J. Blood. Dis. 2012, 2:22-29.
14. Meszaros Z., Borsiczky D., Mate M., Tarcali J., Szombathy T., Tekes K., Magyar K. Platelet MAO-B activity and serotonin content in patients with dementia: effect of age, medication and disease. Neurochem. Res. 1998, 23:863-868.
15. Kumar A.M., Sevush S., Kumar M., Ruiz J., Eisdorfer C. Peripheral serotonin in Alzheimer's disease. NeuroPsychobiology 1995, 32:9-12.
16. Mimica N., Muck-Seler D., Pivac N., Mustapic M., Folnegovic-Smalc V. Platelet serotonin and monoamine oxidase activity in patients with early-onset and late-onset of Alzheimer's disease. Period. Biol. 2005, 107:211-215.
17. Muck-Seler D., Presecki P., Mimica N., Mustapic M., Pivac N., Babic A., Nedic G., Folnegovic-Smalc V. Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease. ProgNeuro-Psychopharmacol. Biol. Psychiatry 2009, 33:1226-1231.
18. Mimica N., Muck-Seler D., Pivac N., Mustapic M., Dezeljin M., Stipcevic T., Presecki P., Radonić E., Folnegović-Smalc V. Platelet serotonin and monoamine oxidase in Alzheimer's disease with psychotic features. Coll. Antropol. 2008, 32(Suppl 1):119-122.
19. Prokšelj T., Jerin A., Kogoj A. Memantine may affect pseudobulbar affect in patients with Alzheimer's disease. Acta Neuropsychiatrica 2013, 25(6):361-366.
20. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC, text rev. fourth ed.
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health & Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34(7):934-944.
22. Rakusa M., Granda G., Kogoj A., Mlakar J., Vodusek D.B. Mini-mental state examination: standardization and validation for the elderly Slovenian population. Eur. J. Neurol. 2006, 13:141-145.
23. Coccaro E.F., Harvey P.D., Kupsaw-Lawrence E., Herbert J.L., Bernstein D.P. Development of neuropharmacologically-based behavioral assessments of impulsive aggressive behavior. J. Neuropsychiatry Clin. Neurosci. 1991, 3:44-51.
24. Robinson R.G., Parikh R.M., Lipsley J.R., Starkstein S.E., Price T.R. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am. J. Psychiatry 1993, 150:286-293.
25. Haupt M. Emotional lability, intrusiveness, and catastrophic reactions. Int. Psychogeriatr. 1996, 8(Suppl 3):409-414.
26. Andersen G., Ingeman-Nielsen M., Vestergaard K., Riis J.O. Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke 1994, 25:1050-1052.
27. Murai T., Barthel H., Berrouschot J., Sorger D., Von Cramon D.Y., Muller U. Neuroimaging of serotonin transporters in post-stroke pathological crying. Psychiatry Res. Neuroimage 2003, 123:207-211.
28. Møller M., Andersen G., Gjedde A. Serotonin 5HT1A receptor availability and pathological crying after stroke. Acta Neurol. Scand. 2007, 116:83-90.
29. Bermack J.E., Debonnel G. The role of sigma receptors in depression. J. Pharmacol. Sci. 2005, 97:317-336.
30. Engelborghs S., Vloeberghs E., Maertens K., Marescau B., De Deyn P.P. Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:1080.
31. Lai M.K., Tsang S.W., Francis P.T., Esiri M.M., Keene J., Hope T., Chen C.P. Reduced 5-HT1 receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res. 2003, 974:82-87.